(PHILADELPHIA) -- In a cancer treatment breakthrough 20 years in the making, researchers from the University of Pennsylvania's Abramson Cancer Center and Perelman School of Medicine have shown sustained remissions of up to a year among a small group of advanced chronic lymphocytic leukemia (CLL) patients treated with genetically engineered versions of their own T cells.
A report issued by the Annenberg Public Policy Center is cited.
PHILADELPHIA — Flax has been part of human history for well over 30,000 years, used for weaving cloth, feeding people and animals, and even making paint. Now, researchers from the Perelman School of Medicine at the University of Pennsylvania have discovered that it might have a new use for the 21st century: protecting healthy tissues and organs from the harmful effects of radiation.
Philadelphia — In the latest issue of Nature, researchers at the Perelman School of Medicine at the University of Pennsylvania clarify the role of two proteins key to T-cell development. They found that one well-known protein called Notch passes off much of its role during T-cell maturation to another protein called TCF-1.
PHILADELPHIA — It’s not every day that researchers get access to a mouse that’s been to space and back, and, with the Space Shuttle program now scuttled, future chances will be even harder to come by.
PHILADELPHIA — Men are more likely than die from injury than are women.
Susan B. Sorenson, a professor at the University of Pennsylvania School of Social Policy & Practice, has evaluated nearly 30 years of national injury mortality data and found that men are at greater risk of injury mortality throughout their lives.